Literature DB >> 22301281

Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Ji-Hyun Jang1, Michelle Cotterchio, Ayelet Borgida, Steven Gallinger, Sean P Cleary.   

Abstract

Individual susceptibility to the toxic effects of cigarette smoke may be modified by inherited variability in carcinogen metabolism. The purpose of the present study was to investigate pancreatic cancer risk associated with cigarette smoking and 33 variants within carcinogen metabolism genes and examine whether these variants modify the association between smoking and pancreatic cancer. A population-based study was conducted with 455 pancreatic cancer cases and 893 controls. Epidemiological and smoking data were collected from questionnaires and variants were genotyped by mass spectrometry. Age- and sex-adjusted odds ratio (ASOR) and multivariate-adjusted odds ratio (MVOR) estimates were obtained using multivariate logistic regression, and interactions between each variant and smoking were investigated. Current smoker status [MVOR = 2.29, 95% confidence interval (95% CI): 1.62, 3.22], 10-27 pack-years (MVOR = 1.57, 95% CI: 1.13, 2.18), >27 pack-years (MVOR = 1.77, 95% CI: 1.27, 2.46) and longer durations of smoking (19-32 years: MVOR = 1.46, 95% CI: 1.05, 2.05; >32 years: MVOR = 1.78, 95% CI: 1.30, 2.45) were associated with increased pancreatic cancer risk. CYP1B1-4390-GG (ASOR = 0.36, 95% CI: 0.15, 0.86) and Uridine 5'-diphospho glucuronosyltransferase 1 family, polypeptide A7-622-CT (ASOR = 0.77, 95% CI: 0.60, 0.99) were associated with reduced risk. N-acetyltransferase 1-640-GT/GG (ASOR = 1.75, 95% CI: 1.00, 3.05), GSTM1 (rs737497)-GG (ASOR = 1.41, 95% CI: 1.02, 1.95), GSTM1 gene deletion (ASOR = 4.89, 95% CI: 3.52, 6.79) and glutathione S-transferase theta-1 gene deletion (ASOR = 4.41, 95% CI: 2.67, 7.29) were associated with increased risk. Significant interactions were observed between pack-years and EPHX1-415 (P = 0.04) and smoking status and N-acetyltransferase 2-857 (P = 0.03). Variants of carcinogen metabolism genes are independently associated with pancreatic cancer risk and may modify the risk posed by smoking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301281      PMCID: PMC3324443          DOI: 10.1093/carcin/bgs028

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  53 in total

1.  Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system.

Authors:  A J Hanley; K C Johnson; P J Villeneuve; Y Mao
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

2.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Ontario familial colon cancer registry: methods and first-year response rates.

Authors:  M Cotterchio; G McKeown-Eyssen; H Sutherland; G Buchan; M Aronson; A M Easson; J Macey; E Holowaty; S Gallinger
Journal:  Chronic Dis Can       Date:  2000

4.  Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.

Authors:  Li Jiao; Melissa L Bondy; Manal M Hassan; David Z Chang; James L Abbruzzese; Douglas B Evans; Michael H Smolensky; Donghui Li
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

5.  A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk.

Authors:  Eric J Duell; Elizabeth A Holly; Paige M Bracci; Mei Liu; John K Wiencke; Karl T Kelsey
Journal:  J Natl Cancer Inst       Date:  2002-02-20       Impact factor: 13.506

6.  Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.

Authors:  C Guillemette; J K Ritter; D J Auyeung; F K Kessler; D E Housman
Journal:  Pharmacogenetics       Date:  2000-10

7.  Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Authors:  Sean P Cleary; Robert Gryfe; Maha Guindi; Paul Greig; Lloyd Smith; Robert Mackenzie; Steven Strasberg; Sherif Hanna; Bryce Taylor; Bernard Langer; Steven Gallinger
Journal:  J Am Coll Surg       Date:  2004-05       Impact factor: 6.113

8.  Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus.

Authors:  Adrian J Fretland; Uday S Devanaboyina; Mark A Doll; Shuang Zhao; Gong H Xiao; David W Hein
Journal:  Toxicol Sci       Date:  2003-05-28       Impact factor: 4.849

9.  UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer.

Authors:  Johann Ockenga; Arndt Vogel; Niels Teich; Volker Keim; Michael P Manns; Christian P Strassburg
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

10.  Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.

Authors:  G Liu; P Ghadirian; D Vesprini; N Hamel; A J Paradis; G Lal; S Gallinger; S A Narod; W D Foulkes
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  19 in total

1.  Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Wen-Xia Sun; Ying-Hua Chen; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Xu-Liang Shen; Xiao-Feng He; Li-Xia Wu; Wu Wei; Lin Zhang
Journal:  Mol Genet Genomics       Date:  2014-12-04       Impact factor: 3.291

2.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

3.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

4.  Epidemiology of Pancreatic and Periampullary Cancer.

Authors:  Prabin Thapa
Journal:  Indian J Surg       Date:  2015-10-17       Impact factor: 0.656

Review 5.  Molecular understanding of lung cancers-A review.

Authors:  Chinnappan Ravinder Singh; Kandasamy Kathiresan
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 6.  The epidemiology of pancreatitis and pancreatic cancer.

Authors:  Dhiraj Yadav; Albert B Lowenfels
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

7.  Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Geoffrey Liu; Steven Gallinger; Sean P Cleary
Journal:  Mol Carcinog       Date:  2013-06-12       Impact factor: 4.784

8.  Dysfunction of mitochondria due to environmental carcinogens in nasopharyngeal carcinoma in the ethnic group of Northeast Indian population.

Authors:  Sankar Kumar Ghosh; Anil Seram Singh; Rosy Mondal; Wetetsho Kapfo; V Khamo; Y Indibor Singh
Journal:  Tumour Biol       Date:  2014-04-09

9.  EPHX1 rs2234922 polymorphism and lung cancer susceptibility in Asian populations: a meta-analysis.

Authors:  Xuefang Xu; Hongxia Hua; Bing Fan; Qing Sun; Xuedan Guo; Jiawei Zhang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

10.  Significant association between GSTT1 null genotype and susceptibility to pancreatic cancer.

Authors:  Xianmin Bu; Chenghai Zhao
Journal:  Mol Biol Rep       Date:  2013-05-30       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.